<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Thorac Cancer</journal-id>
      <journal-id journal-id-type="iso-abbrev">Thorac Cancer</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1759-7714</journal-id>
      <journal-id journal-id-type="publisher-id">TCA</journal-id>
      <journal-title-group>
        <journal-title>Thoracic Cancer</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1759-7706</issn>
      <issn pub-type="epub">1759-7714</issn>
      <publisher>
        <publisher-name>John Wiley &amp; Sons Australia, Ltd</publisher-name>
        <publisher-loc>Melbourne</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28102935</article-id>
      <article-id pub-id-type="pmc">5334324</article-id>
      <article-id pub-id-type="doi">10.1111/1759-7714.12403</article-id>
      <article-id pub-id-type="publisher-id">TCA12403</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Case Report</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Case Reports</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ectopic <styled-content style="fixed-case">C</styled-content>ushing syndrome in small cell lung cancer: <styled-content style="fixed-case">A</styled-content> case report and literature review</article-title>
        <alt-title alt-title-type="right-running-head">A case of Ectopic <styled-content style="fixed-case">C</styled-content>ushing syndrome</alt-title>
        <alt-title alt-title-type="left-running-head">H. Zhang &amp; J. Zhao</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="tca12403-cr-0001" contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Hang&#x2010;yu</given-names>
          </name>
          <xref ref-type="aff" rid="tca12403-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="tca12403-cr-0002" contrib-type="author" corresp="yes">
          <name>
            <surname>Zhao</surname>
            <given-names>Jun</given-names>
          </name>
          <address>
            <email>ohjerry@163.com</email>
          </address>
          <xref ref-type="aff" rid="tca12403-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="tca12403-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Department of Interventional Therapy, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)</named-content>
        <institution>Peking University Cancer Hospital and Institute</institution>
        <named-content content-type="city">Beijing</named-content>
        <country country="CN">China</country>
      </aff>
      <aff id="tca12403-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Department of Thoracic Medical Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)</named-content>
        <institution>Peking University Cancer Hospital and Institute</institution>
        <named-content content-type="city">Beijing</named-content>
        <country country="CN">China</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Jun Zhao, Department of Thoracic Medical Oncology, Peking University Cancer Hospital, No. 52 Fucheng Road, Haidian District, Beijing 100142, China.<break/>
Tel: +86 135 2146 9355Fax: +86 10 8819 6562<break/>
Email: <email>ohjerry@163.com</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>11</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>8</volume>
      <issue>2</issue>
      <issue-id pub-id-type="doi">10.1111/tca.2017.8.issue-2</issue-id>
      <fpage>114</fpage>
      <lpage>117</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>29</day>
          <month>9</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>04</day>
          <month>10</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 China Lung Oncology Group and John Wiley & Sons Australia, Ltd <copyright-statement>-->
        <copyright-statement content-type="article-copyright">&#xA9; 2016 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley &amp; Sons Australia, Ltd</copyright-statement>
        <license license-type="creativeCommonsBy-nc">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x2010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:TCA-8-114.pdf"/>
      <abstract>
        <p>Small cell lung cancer (<styled-content style="fixed-case">SCLC</styled-content>) is a neuroendocrine tumor with the potential to secrete various peptides or hormones that can lead to paraneoplastic syndromes, such as <styled-content style="fixed-case">E</styled-content>ctopic <styled-content style="fixed-case">C</styled-content>ushing syndrome (<styled-content style="fixed-case">ECS</styled-content>). Because of the aggressive nature of the syndrome and its atypical features, <styled-content style="fixed-case">ECS</styled-content> in small&#x2010;cell lung cancer is difficult to diagnose and has a poor prognosis. We report a case of a 74&#x2010;year&#x2010;old male patient who presented with severe hypokalemia, proximal muscle weakness, peripheral edema, metabolic alkalosis, and worsening hyperglycemia. The patient was eventually diagnosed with stage <styled-content style="fixed-case">IV</styled-content> primary small&#x2010;cell lung cancer and survived three&#x2009;months after diagnosis. We reviewed published articles to determine any new diagnostic techniques or advantages in the treatment regimen.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="tca12403-kwd-0001"><styled-content style="fixed-case">E</styled-content>ctopic <styled-content style="fixed-case">C</styled-content>ushing&#x2019;s syndrome</kwd>
        <kwd id="tca12403-kwd-0002">paraneoplastic syndromes</kwd>
        <kwd id="tca12403-kwd-0003">small&#x2010;cell lung cancer</kwd>
      </kwd-group>
      <counts>
        <fig-count count="3"/>
        <table-count count="1"/>
        <page-count count="1"/>
        <word-count count="1950"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>tca12403</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>March 2017</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.8 mode:remove_FC converted:02.03.2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="tca12403-sec-0001">
      <title>Introduction</title>
      <p>Ectopic Cushing&#x2019;s syndrome (ECS) is the second most common paraneoplastic syndrome that occurs with small cell lung cancer (SCLC) (1&#x2013;5% of cases).<xref rid="tca12403-bib-0001" ref-type="ref">1</xref> Up to 50% of ECS cases are lung tumors, including carcinoid tumors (30&#x2013;46% ECS cases) and SCLC (8&#x2013;20% ECS cases).<xref rid="tca12403-bib-0002" ref-type="ref">2</xref>, <xref rid="tca12403-bib-0003" ref-type="ref">3</xref>, <xref rid="tca12403-bib-0004" ref-type="ref">4</xref> SCLC patients with ECS have a poorer prognosis because of their advanced stage, poor response to chemotherapy, increased susceptibility to severe infections, and greater incidence of thromboembolic phenomena.<xref rid="tca12403-bib-0005" ref-type="ref">5</xref>, <xref rid="tca12403-bib-0006" ref-type="ref">6</xref> Most patients present electrolyte disturbances and muscle weakness rather than the typical clinical features of Cushing&#x2019;s syndrome (CS). Studies have suggested that SCLC patients with adrenal metastases may also tend to develop ECS as a result of their location, as corticosteroids are synthesized more abundantly in the areas adjacent to the adrenal metastasis.<xref rid="tca12403-bib-0007" ref-type="ref">7</xref> We report a case of SCLC with Cushing&#x2019;s syndrome and bilateral adrenal metastases in a 74&#x2010;year&#x2010;old man presenting with severe hypokalemia, proximal muscle weakness, peripheral edema, metabolic alkalosis, and worsening hyperglycemia. Clinical features, diagnosis, treatment, and new developments in ECS are discussed.</p>
    </sec>
    <sec id="tca12403-sec-0002">
      <title>Case report</title>
      <p>A 74&#x2010;year&#x2010;old man with a history of 20 pack&#x2010;years smoking and 18&#x2009;years of type 2 diabetes mellitus (T2DM) suffered general weakness and worsening hyperglycemia for a month. His initial blood pressure was 135/70&#x2009;mmHg, his respiratory rate 20 breaths per minute, heart rate 81 beats per minute, and he had a normal temperature. He was categorized as Eastern Cooperative Oncology Group (ECOG) grade 2.</p>
      <p>A laboratory examination revealed the following: white blood cell count, 10.42&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L; neutrophil, 90.74%; hemoglobin, 14.3&#x2009;g/dL; platelet count, 203&#x2009;&#xD7;&#x2009;10<sup>9</sup>/L; potassium, 2.95&#x2009;mmol/L; calcium, 1.91&#x2009;mmol/L; serum alanine aminotransferase, 93&#x2009;IU/L; aspartate aminotransferase, 43&#x2009;IU/L; D&#x2010;dimer, 8.18&#x2009;&#x3BC;g/mL; and C&#x2010;reactive peptide, 3.7&#x2009;mg/L. Arterial blood gas analysis resulted in pH 7.511, pCO<sub>2</sub> 37.3&#x2009;mmHg, pO<sub>2</sub> 67.3&#x2009;mmHg, Glu 13.1&#x2009;mmol/L, Lac 3.6&#x2009;mmol/L, BE 5.95&#x2009;mmol/L and oxygen saturation of 95.8%, which indicated metabolic alkalosis. The patient&#x2019;s adrenocorticotropic hormone&#x2009;level was 299.10&#x2009;PG/Ml (7.2&#x2013;63.3&#x2009;PG/mL) and serum cortisol level was &gt;63.44&#x2009;&#x3BC;g/dL (4.4&#x2013;19.9&#x2009;&#x3BC;g/dL), which indicated CS.</p>
      <p>Chest enhanced computed tomography (CT) scans showed a right lower lobe mass, conformed to malignant features with mediastinal and right hilar lymph node metastasis and double lung metastases (Fig <xref rid="tca12403-fig-0001" ref-type="fig">1</xref>). Abdominal enhanced CT scans showed multiple occupied lesions in the liver, considered as metastases. Bilateral adrenal nodules were also considered as metastases (Figs <xref rid="tca12403-fig-0002" ref-type="fig">2</xref>, <xref rid="tca12403-fig-0003" ref-type="fig">3</xref>). Pituitary imaging was normal. A biopsy was performed with CT&#x2010;guided lung puncture and the pathology confirmed small cell carcinoma.</p>
      <fig fig-type="Figure" xml:lang="en" id="tca12403-fig-0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Right lower lobe mass conforms to malignant features with mediastinal and right hilar lymph node metastasis.</p>
        </caption>
        <graphic id="nlm-graphic-1" xlink:href="TCA-8-114-g003"/>
      </fig>
      <fig fig-type="Figure" xml:lang="en" id="tca12403-fig-0002" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Multiple occupied lesions in the liver, considered metastases.</p>
        </caption>
        <graphic id="nlm-graphic-3" xlink:href="TCA-8-114-g002"/>
      </fig>
      <fig fig-type="Figure" xml:lang="en" id="tca12403-fig-0003" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Bilateral adrenals nodules, considered metastases.</p>
        </caption>
        <graphic id="nlm-graphic-5" xlink:href="TCA-8-114-g001"/>
      </fig>
      <p>After confirmation of the diagnosis, the patient received spironolactone and intravenous potassium supplementation to treat the refractory hypokalemia. Considering the poor performance status of this patient, we suggested oral etoposide in the first cycle at 50&#x2009;mg per day, days 1&#x2013;10, every three&#x2009;weeks. Treatment was ceased on the eighth day because of diarrhea (Common Terminology Criteria for Adverse Events grade 2). In the second cycle, the patient received etoposide via intravenous infusion. During treatment his electrolyte imbalances were corrected, the target lesions in the lung were slightly reduced, and his general state was much better. However, systemic chemotherapy was ceased because of the onset of herpes zoster. The patient died of liver failure three&#x2009;months after diagnosis.</p>
      <p>The limitations faced in this case included the lack of availability of 24&#x2010;hour urine cortisol and inferior petrosal sinus sampling (IPSS). However, the diagnosis was based on strong clinical grounds, firm laboratory findings of hypercortisolism, the exclusion of other causes of CS, histopathologic findings, and clinical improvement after chemotherapy.</p>
    </sec>
    <sec id="tca12403-sec-0003">
      <title>Discussion</title>
      <p>Ectopic Cushing&#x2019;s syndrome secondary to lung cancer is rare and limited papers have reported this syndrome since it was first described by Brown in 1928.<xref rid="tca12403-bib-0004" ref-type="ref">4</xref> ECS in SCLC does not usually exhibit the classic signs of CS and CS could also appear during effective chemotherapy.<xref rid="tca12403-bib-0008" ref-type="ref">8</xref>, <xref rid="tca12403-bib-0009" ref-type="ref">9</xref> The wide variety of clinical manifestations make it more difficult to diagnose ECS in SCLC, especially at early clinical stages.</p>
      <p>Small&#x2010;cell lung cancer patients with ECS have a very poor prognosis, living only three to six&#x2009;months. This makes early diagnosis much more important. IPSS is the most reliable examination for ECS, but it may not be feasible in many institutes.<xref rid="tca12403-bib-0003" ref-type="ref">3</xref>, <xref rid="tca12403-bib-0010" ref-type="ref">10</xref> Complete imaging examination, related blood and urine tests, low dose and high dose dexamethasone tests, immunohistochemical characteristics, and cell proliferation potential (Ki&#x2010;67) should be considered when suspicious of ECS. If a lesion cannot be located on CECT, then ostroscan will also not be effective for detection.<xref rid="tca12403-bib-0003" ref-type="ref">3</xref>, <xref rid="tca12403-bib-0011" ref-type="ref">11</xref>
</p>
      <p>Jeong <italic>et al.</italic> suggested that controlling the high cortisol level and then administering systemic chemotherapy may achieve longer survival.<xref rid="tca12403-bib-0012" ref-type="ref">12</xref> With the exception of systemic chemotherapy, ketoconazole, metyrapone, etomidate, mitotane, and mifepristone can be used to reduce circulating glucocorticoids.<xref rid="tca12403-bib-0005" ref-type="ref">5</xref> Previous reports have shown that there is a tendency to prolong survival when the high level of cortisol is controlled before initiating treatment (Table <xref rid="tca12403-tbl-0001" ref-type="table-wrap">1</xref>). Ketoconazole has been widely accepted for the treatment of ECS since first reported in 1985 because of patient tolerance in spite of moderate toxicity, such as nausea and liver injury.<xref rid="tca12403-bib-0016" ref-type="ref">16</xref> However, ketoconazole may increase the risk of chemotherapy toxicity because it is a strong inhibitor of cytochrome P450 3A4. Thus, metyrapone has been reported to be a better choice. For severe adrenocorticotropic hormone&#x2010;dependent CS, metyrapone and ketoconazole combination or mitotane, metyrapone, and ketoconazole combination therapy could be an alternative to control the cortisol level earlier. Chemotherapy remains the basic treatment for such patients; however, when the clinical manifestation of CS is so severe that the patient cannot tolerate chemotherapy, metyrapone should be administered.</p>
      <table-wrap id="tca12403-tbl-0001" xml:lang="en" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Reports of <styled-content style="fixed-case">ECS</styled-content> in <styled-content style="fixed-case">SCLC</styled-content>
</p>
        </caption>
        <table frame="hsides" rules="groups">
          <col span="1"/>
          <col align="char" char="." span="1"/>
          <col align="char" char="." span="1"/>
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <col align="left" span="1"/>
          <col span="1"/>
          <thead valign="bottom">
            <tr style="border-bottom:solid 1px #000000">
              <th valign="bottom" rowspan="1" colspan="1">Author</th>
              <th align="char" valign="bottom" rowspan="1" colspan="1">Year</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Patient no.</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Clinical presentation</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Treatment</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Survival</th>
              <th align="left" valign="bottom" rowspan="1" colspan="1">Follow&#x2010;up</th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td valign="top" rowspan="1" colspan="1">Shepherd<xref rid="tca12403-bib-0013" ref-type="ref">13</xref>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">1992</td>
              <td align="left" valign="top" rowspan="1" colspan="1">23</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Edema (83%)Muscle weakness (61%)
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Chemotherapy</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3.5&#x2009;months</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Ilias<sup>3</sup>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">2005</td>
              <td align="left" valign="top" rowspan="1" colspan="1">3</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Muscle weakness (82%)Hypertension (78%)
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Chemotherapy with/without endocrine therapy</td>
              <td align="left" valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1">1&#x2013;48&#x2009;months</td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Hadem<xref rid="tca12403-bib-0014" ref-type="ref">14</xref>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">2007</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Muscle weaknessHyperglycemia Hypokalemia
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">KetoconazoleChemotherapy
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2&#x2009;months</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Suyama<xref rid="tca12403-bib-0009" ref-type="ref">9</xref>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">2011</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">HypokalemiaDiabetes<break/>
Hypertension
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">MitotaneChemotherapy
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">5&#x2009;months</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Jeong<xref rid="tca12403-bib-0012" ref-type="ref">12</xref>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">2015</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Hypokalemia metabolic alkalosisHypertension
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">KetoconazoleSpironolactone<break/>
Chemotherapy
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">15&#x2009;months</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Ghazi<xref rid="tca12403-bib-0004" ref-type="ref">4</xref>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">2015</td>
              <td align="left" valign="top" rowspan="1" colspan="1">4</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Muscle weaknessHyperglycemia<break/>
Hypokalemia
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Not mentioned</td>
              <td align="left" valign="top" rowspan="1" colspan="1">2&#x2009;weeks to 3&#x2009;months</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Aoki<xref rid="tca12403-bib-0015" ref-type="ref">15</xref>
</td>
              <td align="char" valign="top" rowspan="1" colspan="1">2016</td>
              <td align="left" valign="top" rowspan="1" colspan="1">1</td>
              <td align="left" valign="top" rowspan="1" colspan="1">HypertensionHypokalemia<break/>
Muscle weakness
</td>
              <td align="left" valign="top" rowspan="1" colspan="1">Chemotherapy</td>
              <td align="left" valign="top" rowspan="1" colspan="1">6&#x2009;months</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tca12403-note-0002">
            <p>ECS, Ectopic Cushing&#x2019;s syndrome; SCLC, small&#x2010;cell lung cancer.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>In conclusion, SCLC with ECS is a rare disease with a poor prognosis. Early diagnosis is challenging but important. SCLC patients with muscle weakness, new onset or worsening hyperglycemia, severe hypokalemia, and bilateral adrenal metastasis should receive adequate attention and extensive examination should be conducted to confirm a diagnosis. Systemic chemotherapy with steroidogenesis inhibitors or glucocorticoid receptor antagonist represents a new treatment regimen. Control of severe hypercortisolism before administering systemic chemotherapy may achieve longer survival.</p>
    </sec>
    <sec id="tca12403-sec-0005">
      <title>Disclosure</title>
      <p>No authors report any conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack id="tca12403-sec-0004">
      <title>Acknowledgments</title>
      <p>Author contributions are as follows: Dr. Zhang contributed to data collection, manuscript drafting and literature research. Dr. Zhao contributed to clinical treatment and manuscript revision for important intellectual content. The authors thank the patient who participated in this study.</p>
    </ack>
    <ref-list id="tca12403-bibl-0001" content-type="cited-references">
      <title>References</title>
      <ref id="tca12403-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0001">
<string-name>
<surname>Mayer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cypess</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kocher</surname>
<given-names>ON</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Uncommon presentations of some common malignancies: Case 1. Sequential paraneoplastic endocrine syndromes in small&#x2010;cell lung cancer</article-title>. <source>J Clin Oncol</source>
<year>2005</year>; <volume>23</volume>: <fpage>1312</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">15718329</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0002">
<string-name>
<surname>Isidori</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Kaltsas</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Pozza</surname>
<given-names>C</given-names>
</string-name>
<italic>et al.</italic>
<article-title>The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long&#x2010;term follow&#x2010;up</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2006</year>; <volume>91</volume>: <fpage>371</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">16303835</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0003">
<string-name>
<surname>Ilias</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Torpy</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Pacak</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mullen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wesley</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Nieman</surname>
<given-names>LK</given-names>
</string-name>. <article-title>Cushing&#x2019;s syndrome due to ectopic corticotropin secretion: Twenty years&#x2019; experience at the National Institutes of Health</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2005</year>; <volume>90</volume>: <fpage>4955</fpage>&#x2013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">15914534</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0004">
<string-name>
<surname>Ghazi</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Abbasi Dezfooli</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Amirbaigloo</surname>
<given-names>A</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Ectopic Cushing&#x2019;s syndrome secondary to lung and mediastinal tumours &#x2010;&#x2010; report from a tertiary care centre in Iran</article-title>. <source>Endokrynol Pol</source>
<year>2015</year>; <volume>66</volume>: <fpage>2</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">25754275</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0005">
<string-name>
<surname>Kanaji</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Watanabe</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kita</surname>
<given-names>N</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Paraneoplastic syndromes associated with lung cancer</article-title>. <source>World J Clin Oncol</source>
<year>2014</year>; <volume>5</volume>: <fpage>197</fpage>&#x2013;<lpage>223</lpage>.<pub-id pub-id-type="pmid">25114839</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0006">
<string-name>
<surname>von Stempel</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Perks</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Corcoran</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Grayez</surname>
<given-names>J</given-names>
</string-name>. <article-title>Cardio&#x2010;respiratory failure secondary to ectopic Cushing&#x2019;s syndrome as the index presentation of small&#x2010;cell lung cancer</article-title>. <source>BMJ Case Rep</source>
<year>2013</year>; <volume>2013</volume>: <fpage>pii: bcr2013009974</fpage>.</mixed-citation>
      </ref>
      <ref id="tca12403-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0007">
<string-name>
<surname>Satoh</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hisata</surname>
<given-names>S</given-names>
</string-name>
<italic>et al.</italic>
<article-title>An ectopic ACTH&#x2010;producing small cell lung carcinoma associated with enhanced corticosteroid biosynthesis in the peritumoral areas of adrenal metastasis</article-title>. <source>Lung Cancer</source>
<year>2012</year>; <volume>76</volume>: <fpage>486</fpage>&#x2013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">22251774</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0008">
<string-name>
<surname>Imura</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Matsukura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hirata</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nakai</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Studies on ectopic ACTH&#x2010;producing tumors. II. Clinical and biochemical features of 30 cases</article-title>. <source>Cancer</source>
<year>1975</year>; <volume>35</volume>: <fpage>1430</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">164276</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0009">
<string-name>
<surname>Suyama</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Naito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yoh</surname>
<given-names>K</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Development of Cushing&#x2019;s syndrome during effective chemotherapy for small cell lung cancer</article-title>. <source>Intern Med</source>
<year>2011</year>; <volume>50</volume>: <fpage>335</fpage>&#x2013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">21325767</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0010">
<string-name>
<surname>Kolesnikova</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Lapshina</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Voronkova</surname>
<given-names>IA</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Comparative analysis of clinical, hormonal and morphological studies in patients with neuroendocrine ACTH&#x2010;producing tumours</article-title>. <source>Int J Endocrinol</source>
<year>2013</year>; <volume>2013</volume>: <fpage>659232</fpage>.<pub-id pub-id-type="pmid">23509456</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0011">
<string-name>
<surname>Alexandraki</surname>
<given-names>KI</given-names>
</string-name>, <string-name>
<surname>Grossman</surname>
<given-names>AB</given-names>
</string-name>. <article-title>The ectopic ACTH syndrome</article-title>. <source>Rev Endocr Metab Disord</source>
<year>2010</year>; <volume>11</volume>: <fpage>117</fpage>&#x2013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">20544290</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0012">
<string-name>
<surname>Jeong</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ryu</surname>
<given-names>S</given-names>
</string-name>
<italic>et al.</italic>
<article-title>A case of ectopic adrenocorticotropic hormone syndrome in small cell lung cancer</article-title>. <source>Tuberc Respir Dis (Seoul)</source>
<year>2015</year>; <volume>78</volume>: <fpage>436</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26508941</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0013">
<string-name>
<surname>Shepherd</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Laskey</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Goss</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Johansen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Khamsi</surname>
<given-names>F</given-names>
</string-name>. <article-title>Cushing&#x2019;s syndrome associated with ectopic corticotropin production and small&#x2010;cell lung cancer</article-title>. <source>J Clin Oncol</source>
<year>1992</year>; <volume>10</volume>: <fpage>21</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">1309381</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0014">
<string-name>
<surname>Hadem</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cornberg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>L&#xE4;nger</surname>
<given-names>F</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Making sense of muscle fatigue and liver lesions</article-title>. <source>Z Gastroenterol</source>
<year>2007</year>; <volume>45</volume>: <fpage>609</fpage>&#x2013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">17620225</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0015">
<string-name>
<surname>Aoki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fujisaka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tokioka</surname>
<given-names>S</given-names>
</string-name>
<italic>et al.</italic>
<article-title>Small&#x2010;cell lung cancer in a young adult nonsmoking patient with ectopic adrenocorticotropin (ACTH) production</article-title>. <source>Intern Med</source>
<year>2016</year>; <volume>55</volume>: <fpage>1337</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">27181543</pub-id></mixed-citation>
      </ref>
      <ref id="tca12403-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="tca12403-cit-0016">
<string-name>
<surname>Shepherd</surname>
<given-names>FA</given-names>
</string-name>, <string-name>
<surname>Hoffert</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>WK</given-names>
</string-name>, <string-name>
<surname>Emery</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Trachtenberg</surname>
<given-names>J</given-names>
</string-name>. <article-title>Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing&#x2019;s syndrome in small&#x2010;cell lung cancer</article-title>. <source>Arch Intern Med</source>
<year>1985</year>; <volume>145</volume>: <fpage>863</fpage>&#x2013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">2986567</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
